These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 2970407)

  • 21. Timing of oocyte retrieval in cycles with a spontaneous luteinizing hormone surge in a large in vitro fertilization program.
    Droesch K; Muasher SJ; Kreiner D; Jones GS; Acosta AA; Rosenwaks Z
    Fertil Steril; 1988 Sep; 50(3):451-6. PubMed ID: 3137100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of GnRH analogue therapy in IVF in women with unexplained infertility.
    Ashkenazi J; Dicker D; Feldberg D; Goldman GA; Yeshaya A; Goldman JA
    Hum Reprod; 1989 Aug; 4(6):667-9. PubMed ID: 2528570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pregnancy rates in an IVF program. Use of the flare-up protocol after failure with long regimens of GnRH-a.
    Karacan M; Erkan H; Karabulut O; Sarikamiş B; Camlibel T; Benhabib M
    J Reprod Med; 2001 May; 46(5):485-9. PubMed ID: 11396377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oocyte retrieval for in vitro fertilization.
    Diedrich K; Van der Ven H; Al-Hasani S; Werner A; Krebs D
    Ann Biol Clin (Paris); 1987; 45(3):351-7. PubMed ID: 2959179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist.
    Itskovitz J; Boldes R; Levron J; Erlik Y; Kahana L; Brandes JM
    Fertil Steril; 1991 Aug; 56(2):213-20. PubMed ID: 1906406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of gonadotropin-releasing hormone analogs for in vitro fertilization: comparison between the standard form and long-acting formulation of D-Trp-6-luteinizing hormone-releasing hormone.
    Vauthier D; Lefebvre G
    Fertil Steril; 1989 Jan; 51(1):100-4. PubMed ID: 2521322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.
    European and Middle East Orgalutran Study Group
    Hum Reprod; 2001 Apr; 16(4):644-51. PubMed ID: 11278211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
    Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
    Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization.
    Mohamed KA; Davies WA; Lashen H
    Gynecol Endocrinol; 2006 Feb; 22(2):57-62. PubMed ID: 16603428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
    Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Peñarrubia J; Rivera F; Vanrell JA
    Gynecol Endocrinol; 1995 Mar; 9(1):51-8. PubMed ID: 7793300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed embryo transfer in an in-vitro fertilization programme: how to avoid working on Sunday.
    Belaisch-Allart J; Briot P; Allart JP; Dufêtre C; Mussy MA; Adle F; Soria B
    Hum Reprod; 1991 Apr; 6(4):541-3. PubMed ID: 1833418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.
    Albano C; Felberbaum RE; Smitz J; Riethmüller-Winzen H; Engel J; Diedrich K; Devroey P
    Hum Reprod; 2000 Mar; 15(3):526-31. PubMed ID: 10686191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal changes induced by short-term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development.
    Loumaye E; Vankrieken L; Depreester S; Psalti I; de Cooman S; Thomas K
    Fertil Steril; 1989 Jan; 51(1):105-11. PubMed ID: 2491990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment variables in relation to oocyte maturation: lessons from a clinical micromanipulation-assisted in vitro fertilization program.
    Avrech OM; Goldman GA; Rufas O; Stein A; Amit S; Yoles I; Pinkas H; Fisch B
    J Assist Reprod Genet; 1997 Jul; 14(6):337-42. PubMed ID: 9226513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of letrozole on women with endometriosis undergoing ovarian stimulation for
    Kim SJ; Choo CW; Kim SK; Lee JR; Jee BC; Suh CS; Lee WD; Kim SH
    Gynecol Endocrinol; 2020 Mar; 36(3):257-260. PubMed ID: 31389274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What are the best predictors for successful GnRH antagonist protocol in in vitro fertilization (IVF) treatment?
    Samara N; Reis D; Danielli Miller N; Ghetler Y; Berkovitz A; Miller M; Gonen O; Shulman A; Wiser A
    Gynecol Endocrinol; 2015; 31(11):877-9. PubMed ID: 26416777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.